Join to View Full Profile
1515 Holcombe BlvdHouston, TX 77030
Phone+1 713-792-6161
Join Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Yun Wu, MD is a board certified pathologist in Houston, Texas. She is currently licensed to practice medicine in Texas and New York.
Education & Training
Memorial Sloan Kettering Cancer Center Oncologic PathologyFellowship, Selective Pathology, 2003 - 2004
University of Texas Southwestern Medical CenterResidency, Pathology-Anatomic and Clinical, 1999 - 2003
Shanghai Medical UniversityClass of 1991
Certifications & Licensure
TX State Medical License 2003 - 2026
NY State Medical License 2002 - 2010
American Board of Pathology Anatomic Pathology & Clinical Pathology
Publications & Presentations
PubMed
- Prospective and Retrospective Analysis of Whole-Slide Images of Sentinel and Targeted Lymph Node Frozen Sections in Breast Cancer.Qiqi Ye, Timothy Law, Dianna Klippel, Constance Albarracin, Hui Chen
Modern Pathology. 2025-04-01 - Infections Due to Corynebacterium kroppenstedtii With Focus on Granulomatous Lobular Mastitis for Tissue Specificity, Pathogenesis, Bacteriologic Workup, and Treatment.Qiong Gan, Yang Ding, Yun Wu, Yu Zhang, Qing H Meng
Archives of Pathology & Laboratory Medicine. 2025-01-13 - 2 citationsMargin Width and Local Recurrence in Patients with Phyllodes Tumors of the Breast.Haydee Del Calvo, Yun Wu, Heather Y Lin, Elise F Nassif, Maria A Zarzour
Annals of Surgical Oncology. 2024-11-01
Press Mentions
Students Present Their Summer Research ProjectsSeptember 13th, 2021- AACR21 Preview: Discovery Science Driving Clinical BreakthroughsApril 5th, 2021
Sfrp1 Protects Against Acute Myocardial Ischemia (AMI) Injury in Aged Mice by Inhibiting the Wnt/Β-catenin Signaling PathwayJanuary 19th, 2021
Grant Support
- Lung Cancer Early Detection and Immunotherapy Response Prediction and Monitoring with an Exo-PROS Liquid Biopsy AssaySTATE UNIVERSITY OF NEW YORK AT BUFFALO2022–2027
- Lung Cancer Early Detection and Immunotherapy Response Prediction and Monitoring with an Exo-PROS Liquid Biopsy AssaySTATE UNIVERSITY OF NEW YORK AT BUFFALO2022–2027
- Lung Cancer Early Detection and Immunotherapy Response Prediction and Monitoring with an Exo-PROS Liquid Biopsy AssaySTATE UNIVERSITY OF NEW YORK AT BUFFALO2022–2027
- Exosomal Thomsen-Friedenreich glycoantigen as a new biomarker for lung cancer screening and early detectionSTATE UNIVERSITY OF NEW YORK AT BUFFALO2022–2025
- Exosomal Thomsen-Friedenreich glycoantigen as a new biomarker for lung cancer screening and early detectionSTATE UNIVERSITY OF NEW YORK AT BUFFALO2022–2025
- Zwitterionic Dendrimer-modified PEG for Protein ConjugationSTATE UNIVERSITY OF NEW YORK AT BUFFALO2021–2025
